Also written by Reutersuk:
Investors Called on to Give Boardroom Leaders Greater Scrutiny
x hide permanently

GSK Boosts Board-Level Science as New CEO Prepares to Take Over

Drugmaker GlaxoSmithKline ( GSK.L ) is bolstering scientific expertise on its board by establishing a new science committee, charged with overseeing research, as a new chief executive prepares to take over...

Mentions: MDC Partners